San Diego, CA, United States of America

Atul Agarwal

This inventor holds 1 USPTO granted patent. Top assignee: Metabasis Therapeutics, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atul Agarwal. Retrieved from https://idiyas.com/inventor/atul-agarwal-sqmc1tdy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atul Agarwal: Innovator in Heteroaromatic Compounds

Introduction

Atul Agarwal is a prominent inventor based in San Diego, California. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic potential. His work focuses on creating innovative solutions to complex biological problems.

Latest Patents

Atul Agarwal holds a patent for "Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase." This invention represents a crucial advancement in the search for effective treatments for metabolic disorders.

Career Highlights

Agarwal is currently associated with Metabasis Therapeutics, Inc., where he applies his expertise in drug discovery and development. His career is marked by a commitment to advancing scientific knowledge and improving patient outcomes through innovative research.

Collaborations

Atul has collaborated with notable colleagues, including Qun Dang and Srinivas Rao Kasibhatla. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Atul Agarwal's contributions to the field of medicinal chemistry exemplify the impact of innovation in healthcare. His work continues to inspire future advancements in the treatment of metabolic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…